Jack Meehan
Stock Analyst at Barclays
(3.06)
# 1,376
Out of 5,044 analysts
137
Total ratings
69.51%
Success rate
21.33%
Average return
Main Sectors:
Stocks Rated by Jack Meehan
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| LH Labcorp Holdings | Maintains: Equal-Weight | $275 → $290 | $259.69 | +11.67% | 17 | Oct 2, 2025 | |
| A Agilent Technologies | Maintains: Underweight | $120 → $125 | $145.85 | -14.30% | 20 | Feb 28, 2024 | |
| WAT Waters | Maintains: Equal-Weight | $275 → $288 | $345.95 | -16.75% | 10 | Aug 3, 2023 | |
| AVTR Avantor | Initiates: Overweight | $33 | $15.06 | +119.12% | 3 | Mar 3, 2021 | |
| ILMN Illumina | Initiates: Underweight | $325 | $97.80 | +232.31% | 8 | Mar 3, 2021 | |
| INMD InMode | Maintains: Overweight | $18 → $19 | $15.28 | +24.35% | 3 | Aug 17, 2020 | |
| DGX Quest Diagnostics | Maintains: Equal-Weight | $93 → $99 | $178.28 | -44.47% | 7 | Apr 23, 2020 | |
| ICLR ICON Public Limited Company | Maintains: Overweight | $170 → $180 | $177.73 | +1.28% | 2 | Apr 23, 2020 | |
| MYGN Myriad Genetics | Maintains: Underweight | $14 → $10 | $8.13 | +23.08% | 8 | Mar 26, 2020 | |
| IQV IQVIA Holdings | Maintains: Overweight | $192 → $166 | $218.13 | -23.90% | 4 | Mar 26, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $51 → $43 | $74.01 | -41.90% | 9 | Mar 26, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $170 → $154 | $187.93 | -18.05% | 7 | Mar 26, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $435 → $430 | $330.42 | +30.14% | 6 | Mar 26, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $435 → $430 | $338.00 | +27.22% | 6 | Mar 26, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Equal-Weight | n/a | $28.19 | - | 10 | Mar 26, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | $52 → $48 | $38.70 | +24.03% | 4 | Mar 26, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Equal-Weight | $720 → $680 | $1,404.58 | -51.59% | 4 | Mar 26, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $28 → $30 | $82.38 | -63.58% | 3 | Oct 2, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $295 → $300 | $557.63 | -46.20% | 5 | Mar 18, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Equal-Weight | $40 | $1.44 | +2,677.78% | 1 | Dec 11, 2017 |
Labcorp Holdings
Oct 2, 2025
Maintains: Equal-Weight
Price Target: $275 → $290
Current: $259.69
Upside: +11.67%
Agilent Technologies
Feb 28, 2024
Maintains: Underweight
Price Target: $120 → $125
Current: $145.85
Upside: -14.30%
Waters
Aug 3, 2023
Maintains: Equal-Weight
Price Target: $275 → $288
Current: $345.95
Upside: -16.75%
Avantor
Mar 3, 2021
Initiates: Overweight
Price Target: $33
Current: $15.06
Upside: +119.12%
Illumina
Mar 3, 2021
Initiates: Underweight
Price Target: $325
Current: $97.80
Upside: +232.31%
InMode
Aug 17, 2020
Maintains: Overweight
Price Target: $18 → $19
Current: $15.28
Upside: +24.35%
Quest Diagnostics
Apr 23, 2020
Maintains: Equal-Weight
Price Target: $93 → $99
Current: $178.28
Upside: -44.47%
ICON Public Limited Company
Apr 23, 2020
Maintains: Overweight
Price Target: $170 → $180
Current: $177.73
Upside: +1.28%
Myriad Genetics
Mar 26, 2020
Maintains: Underweight
Price Target: $14 → $10
Current: $8.13
Upside: +23.08%
IQVIA Holdings
Mar 26, 2020
Maintains: Overweight
Price Target: $192 → $166
Current: $218.13
Upside: -23.90%
Mar 26, 2020
Maintains: Equal-Weight
Price Target: $51 → $43
Current: $74.01
Upside: -41.90%
Mar 26, 2020
Maintains: Equal-Weight
Price Target: $170 → $154
Current: $187.93
Upside: -18.05%
Mar 26, 2020
Maintains: Overweight
Price Target: $435 → $430
Current: $330.42
Upside: +30.14%
Mar 26, 2020
Maintains: Overweight
Price Target: $435 → $430
Current: $338.00
Upside: +27.22%
Mar 26, 2020
Downgrades: Equal-Weight
Price Target: n/a
Current: $28.19
Upside: -
Mar 26, 2020
Upgrades: Overweight
Price Target: $52 → $48
Current: $38.70
Upside: +24.03%
Mar 26, 2020
Upgrades: Equal-Weight
Price Target: $720 → $680
Current: $1,404.58
Upside: -51.59%
Oct 2, 2019
Maintains: Underweight
Price Target: $28 → $30
Current: $82.38
Upside: -63.58%
Mar 18, 2019
Maintains: Overweight
Price Target: $295 → $300
Current: $557.63
Upside: -46.20%
Dec 11, 2017
Initiates: Equal-Weight
Price Target: $40
Current: $1.44
Upside: +2,677.78%